Pasternak Andy
SEC insider (Form 3/4/5 filer). CIK 0001792746. Director at Context Therapeutics Inc. (CNTX) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 24, 2026. Located in PRINCETON, NJ.
Companies Pasternak Andy has filed insider reports for
- Context Therapeutics Inc. (CNTX): Director
- Kardigan, Inc. (KARD): Officer, Chief Strategy Officer
Pasternak Andy
CIK: 0001792746
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 24, 2026CNTX
Context Therapeutics Inc.
AwardDirectStock Option (right to buy)
45K shares- - Jun 17, 2026KARD
Kardigan, Inc.
AwardDirect79.6K shares- - Jun 12, 2025CNTX
Context Therapeutics Inc.
AwardDirectStock Option (right to buy)
138.9K shares- - Jan 13, 2025CNTX
Context Therapeutics Inc.
AwardDirectStock Option (right to buy)
20.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 24, 2026 |  CNTX Context Therapeutics Inc. | Award Stock Option (right to buy) | 45,000 | - | - | Direct |
| Jun 17, 2026 |  KARD Kardigan, Inc. | Award | 79,640 | - | $0 | Direct |
| Jun 12, 2025 | CNTX Context Therapeutics Inc. | Award Stock Option (right to buy) | 138,900 | - | - | Direct |
| Jan 13, 2025 | CNTX Context Therapeutics Inc. | Award Stock Option (right to buy) | 20,685 | - | - | Direct |
1-4 of 4 transactions